Urticarial vasculitis appearing in the progression of systemic sclerosis

Journal of Dermatology

Volumn 33, Issue 11, 2006, Pages 792-797

  Kato, Yoko ^a   Aoki, Mikako ^a   Kawana, Seiji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Limited cutaneous systemic sclerosis; Mast cell; Tryptase; Urticarial vasculitis

Indexed keywords

CEFATRIZINE; PREDNISOLONE; TRYPTASE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MAST CELL; OUTPATIENT DEPARTMENT; SKIN BIOPSY; SYSTEMIC SCLEROSIS; URTICARIA; URTICARIAL VASCULITIS;

EID: 33750298655     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2006.00181.x     Document Type: Article

References (22)

1. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: A histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992; 26: 441-448.
2. Soylu A, Kavukçu S, Uzuner N, Olgaç N, Karaman Ö, Özer E. Systemic lupus erythematosus presenting with normocomplementemic urticarial vasculitis in a 4-year-old girl. Pediatr Int 2001; 43: 420-423.
3. Saigal K, Valencia IC, Cohen J, Kerdel FA. Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: Rapid response to rituximab. J Am Acad Dermatol 2003; 49: S283-285.
4. Alexander EL, Provost TT. Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 1983; 80: 386-391.
5. Hawkins RA, Claman HN, Clark RA, Steigerwald JC. Increased dermal mast cell populations in progressive systemic sclerosis; a link in chronic fibrosis? Ann Intern Med 1985; 102: 182-186.
6. Nishioka K, Kobayashi Y, Katayama I, Takijiri C. Mast cell numbers in diffuse scleroderma. Arch Dermatol 1987; 123: 205-208.
7. Irani AA, Gruber BL, Kaufman LD, Kahaleh MB, Schwartz LB. Mast cell changes in scleroderma. Arthritis Rheum 1992; 35: 933-939.
8. Frieri M. Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 1992; 69: 385-392.
9. Gruber BL. Mast cells in scleroderma. Clin Dermatol 1994; 12: 397-406.
10. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y. Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998; 138: 399-406.
11. 3) and mast cells in the pathogenesis of scleroderma. Clin Rheumatol 2003; 22: 189-195.
12. Kano Y, Orihara M, Shiohara T. Cellular and molecular dynamics in exercise-induced urticarial vasculitis lesions. Arch Dermatol 1998; 134: 62-67.
13. Brennan P, Silman A, Black C et al. Reliability of skin involvement measures in scleroderma. Brit J Rheumatol 1992; 31: 457-460.
14. Asherson RA, Angus H, Mathews JA, Meyers O, Hughes GR. The progressive systemic sclerosis / systemic lupus overlap: an unusual clinical progression, Ann Rheumatic Dis 1991; 50: 323-327.
15. Sanli H, Özdemir E. IgM class anticardiolipin antibody and anti-Ro/SS-A positivity in urticarial vasculitis associated with hepatitis C virus infection. Int J Dermatol 2002; 41: 930-932.
16. Roger D, Rolle F, Mausset J, Lavignac C, Bonnetblanc JM. Urticarial vasculitis induced by fluoxetine. Dermatology 1995; 191: 164.
17. Mitchell GG, Magnusson AR, Weiler JM. Cimetidine-induced cutaneous vasculitis. Am J Med 1983; 75: 875-876.
18. Wilson D, McCluggage WG, Wright GD. Urticarial vasculitis: a paraneoplastic presentation of B-cell non-Hodgkin's lymphoma. Rheumatology 2002; 41: 476-477.
19. Wang CC, Chen MJ, Ho HC, Hong HS. Urticarial vasculitis and dermatomyositis in a patient with nasopharyngeal carcinoma. Cutis 2003; 72: 399-402.
20. O'Donnell B, Black AK. Urticarial vasculitis. Int Angiol 1995; 14: 166-174.
21. Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000; 12: 24-31.
22. Kawana S, Nishiyama S. Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schönlein purpura. Dermatology 1992; 184:171-176.